Hiddo Lambers Heerspink University medical Center GroningenNetherlands

Hiddo Lambers Heerspink is affiliated with the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands. He received his PhD degree from the medical faculty of the University Medical Center Groningen in 2008. He then worked as a post-doctoral fellow at The George Institute in Sydney, Australia where he was trained in clinical trial design and conduct, and investigated the effects of blood pressure lowering regimens on renal and cardiovascular outcomes in patients with CKD. Based on this work, he was awarded a young investigator grant and subsequently in 2015 a consolidator investigator grant from the Dutch organisation of scientific research. rSince 2010, Doctor Lambers Heerspink has held a position as a Clinical Pharmacologist at the University Medical Center Groningen. He is currently Professor Clinical Trials and Personalized Medicine. His main research interests include optimising treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular disease. His particular clinical research interest is to identify determinants of individual treatment responses and ways to optimize drug response in individual patients. To achieve these goals he is involved in various international clinical trials and uses biomarkers and imaging techniques to unravel pathways and determinants of therapy response.

1 APRIL 2023

Time Session
11:45
12:45
Sritippayawan Suchai Chairperson Siriraj Hospital Thailand
Wenjun Ju Chairperson wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Novel Biomarkers in CKD
    Hiddo Lambers Heerspink Speaker University medical Center GroningenNetherlands
  • How to Use Large Omics Data to Understand CKD
    Markus Rinschen Speaker Aarhus University/University Hospital Hamburg EppendorfGermany
  • Mechanisms of the Cardio-Renal Axis
    Salim Hayek Speaker University of MichiganUnited States
  • Q and A
Plenary Halls 2 & 3

30 MARCH 2023

Time Session
08:30
10:30
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Fundamentals of Clinical Trials
    David Wheeler Speaker University College LondonUnited Kingdom
  • Q and A
  • Core Statistics for Trials
    Natalie Staplin Speaker University of OxfordUnited Kingdom
  • Q and A
  • How Can Your Patient Co-design Your Trial?
    Nicki Scholes-Robertson Speaker Flinders UniversityAustralia
    William Herrington Speaker University of OxfordUnited Kingdom
  • Q and A
MR 110
11:00
13:00
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Establishing and Conducting Your Trial
    Hong Zhang Speaker Peking University First HospitalChina
  • Q and A
  • Global Representation in Large Trials
    Hernan Trimarchi Speaker HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Q and A
  • Innovations in Trial Conduct
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
MR 110
14:00
16:00
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Innovations in Trial Design
    Meg Jardine Speaker University of SydneyAustralia
  • Q and A
  • Bayesian Statistics in Trials
    Tom Snelling Speaker Professor in Infectious DiseasesAustralia
  • Q and A
  • Innovations in Trial Outcomes
    Hiddo Lambers Heerspink Speaker University medical Center GroningenNetherlands
  • Q and A
MR 110